Fonti e studi

1. Deutsche Gesellschaft für Rheumatologie e.V. (2015): Rheuma in Zahlen. Betroffene Menschen in Deutschland. https://dgrh.de/Start/DGRh/Presse/Daten-und-Fakten/Rheuma-in-Zahlen.html

2. Coxib and traditional NSAID Trialists’ (CNT) Collaboration (2013): Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet, 382(9894): 769-779.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778977/

3. Johnson, AG., Nguyen TV, Day, RO. (1994): Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis., Annals of internal medicine, 121(4): 289-300.
https://www.ncbi.nlm.nih.gov/pubmed/8037411

4. Leong, RW., Chan, FK. (2006): Drug-induced side effects affecting the gastrointestinal tract. Expert Opin Drug Saf, 5(4): 585-592.
https://www.ncbi.nlm.nih.gov/pubmed/16774495

5. Sostres, C., Gargallo, CJ., Arroyo, MT., Lanas, A. (2010): Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol., Apr 2019, 24(2): 121-132.
https://www.ncbi.nlm.nih.gov/pubmed/20227026

6. Zittlau J., (2015): Was Paracetamol, Ibuprofen & Co gefährlich macht. Die Welt.
http://www.welt.de/gesundheit/article146102233/Was-Paracetamol-Ibuprofen-amp-Co-gefaehrlich-macht.html

7. Coulson, S., Vecchio, P., Gramotnev, H., Vitetta, L. (2012): Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot study. Inflammapharmacology, 20(2): 71-76.
https://www.ncbi.nlm.nih.gov/pubmed/22366869

8. Pollard, B., Guilford, WG., Ankenbauer-Perkins, KL., Hedderley, D. (2006): Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. N Z Vet J, 54(3): 114-118.
https://www.ncbi.nlm.nih.gov/pubmed/16751841

9. Cayzer, J., Hedderley, D., Gray, S. (2012): A randomised, double-blinded, placebo-controlled study on the efficacy of a unique extract of green-lipped mussel (Perna canaliculus) in horses with chronic fetlock lameness attributed to osteoarthritis. Equine Vet J, 44(4): 393-398.
https://www.ncbi.nlm.nih.gov/pubmed/21883418

10. Wegener, T. (2002): Degenerative diseases of the musculoskeletal system--overview of current clinical studies of Devil's Claw (Harpagophyti radix)., Wien Med Wochenschr, 152(15-16): 389-92.
https://www.ncbi.nlm.nih.gov/pubmed/12244884

11. Gagnier, JJ., Chrubasik, S., Manheimer, E. (2004): Harpagophytum procumbens for osteoarthritis and low back pain: a systematic review. BMC Complement Altern Med, 4:13.
https://www.ncbi.nlm.nih.gov/pubmed/15369596

12. Wegener ,T., Lüpke, NP. (2003): Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC.), Phytother Res, 17(10): 1165-1172.
https://www.ncbi.nlm.nih.gov/pubmed/14669250

13. Torres-Fuentes, C., Theeuwes, WF., McMullen, MK., McMullen, AK., Dinan, TG., Cryan, JF., Schellekens, H. (2014): Devil's Claw to suppress appetite--ghrelin receptor modulation potential of a Harpagophytum procumbens root extract, PloS One, 9(7): e103118.
https://www.ncbi.nlm.nih.gov/pubmed/25068823

14. Cameron, M., Chrubasik, S. (2014): Oral herbal therapies for treating osteoarthritis. Cochrane Database Syst Rev, 5: CD002947.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494689/

15. Kimmatkar, N., Thawani, V., Hingorani, L., Khiyani, R. (2003): Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee - a randomized double blind placebo controlled trial. Phytomedicine, 10(1): 3-7.
https://www.ncbi.nlm.nih.gov/pubmed/12622457

16. Reginster, JY., Neuprez, A., Lecart, MP., Sarlet, N., Bruyere, O. (2012): Role of glucosamine in the treatment for osteoarthritis. Rheumatol Int, 32(10): 2959–2967.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456914/

17. Pavelká, K., Gatterová, J., Olejarová, M., Machacek, S., Giacovelli, G., Rovati, LC. (2002): Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med, 162(18): 2113-2123.
https://www.ncbi.nlm.nih.gov/pubmed/12374520

18. Clegg, DO., Reda, DJ., Harris, CL. et al. (2006): Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis, N Engl J Med, 354(8): 795-808.
https://www.ncbi.nlm.nih.gov/pubmed/16495392

19. Bello, AE., Oesser, S. (2006): Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature. Curr Med Res Opin, 22(11): 2221-2232.
https://www.ncbi.nlm.nih.gov/pubmed/17076983

20. Tashiro, T., Seino, S., Sato, T., Matsuoka, R., Masuda, Y., Fukui, N. (2012): Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis, N Engl J Med, 354(8): 795-808.
https://www.ncbi.nlm.nih.gov/pubmed/23226979

21. Kim, LS., Axelrod, LJ., Howard, ND., Buratovich, N., Waters, RF. (2006): Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage, 14(3): 286-294.
https://www.ncbi.nlm.nih.gov/pubmed/16309928

22. Usha, PR., Naidu, MU. (2004): Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis. Clinical Drug Invest, 24(6): 353-363.
https://www.ncbi.nlm.nih.gov/pubmed/17516722

23. Chen, LH. (1989): Interaction of vitamin E and ascorbic acid (review). In Vivo, 3(3):199-209.
https://www.ncbi.nlm.nih.gov/pubmed/2519855

24. Schuppan, D., Pickert, G., Ashfaq-Khan, M., Zevallos, V. (2015): Non-celiac wheat sensitivity: differential diagnosis, triggers and implications. Best Pract Res Clin Gastroenterol, 29(3): 469-476.
https://www.ncbi.nlm.nih.gov/pubmed/26060111